Target intelligence / Profile preview

Mucolipin-2 (TRPML2) (TRPML2)

Target
TRPML2
Molecular classification
Ion channel, Transient receptor potential channel, Receptor
01

Overview

Mucolipin-2 (TRPML2) is a non-selective cation channel belonging to the mucolipin subfamily of the transient receptor potential (TRP) superfamily. It is primarily localized to the membranes of recycling endosomes and lysosomes, with high expression levels found in lymphoid and myeloid cells such as macrophages and B lymphocytes. TRPML2 plays a critical role in the innate immune response by regulating the trafficking and secretion of chemokines, most notably CCL2, and is upregulated following Toll-like receptor (TLR) activation. In the context of infectious diseases, TRPML2 has been shown to influence the endocytic trafficking of enveloped viruses, including Zika, Influenza A, and Yellow Fever, which can paradoxically enhance viral entry or facilitate clearance depending on the cellular context. Furthermore, TRPML2 is implicated in cancer progression, particularly in glioblastoma, where its high expression supports tumor cell viability and proliferation. Pharmacological modulation of TRPML2 using selective small-molecule agonists like ML2-SA1 is currently being explored as a strategy to enhance immune defense and correct endolysosomal trafficking defects.

Other names
MCOLN2Mucolipin TRP Cation Channel 2TRP-ML2Transient Receptor Potential Channel Mucolipin 2FLJ36691
02

Mechanism of action

Agonism of the TRPML2 cation channel promotes the release of calcium and sodium from endolysosomal compartments into the cytosol, which triggers vesicular trafficking, enhances the secretion of chemokines such as CCL2, and modulates immune cell activation and viral processing.

03

Biological functions

Endolysosomal traffickingCation transportImmune responseChemokine secretionOsmo-mechanosensationAutophagy
04

Disease associations

InfectionInflammationCancerNeurodegenerative disease
05

Safety considerations

Potential enhancement of viral entry and trafficking for certain enveloped viruses like Zika and InfluenzaRisk of off-target effects on TRPML1 and TRPML3 due to high sequence homologyPro-tumorigenic potential in specific cancers such as glioblastoma where TRPML2 promotes cell survivalPotential for inflammatory over-activation due to increased chemokine release
06

Interacting drugs

ML2-SA1

5 more in the full profile.

07

Biomarkers

CCL2 (Monocyte Chemoattractant Protein-1) levelsTRPML2 mRNA expression in macrophagesTRPML2 protein levels in glioma tissue

Beyond the preview

Go deeper on Mucolipin-2 (TRPML2) (TRPML2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucolipin-2 (TRPML2) (TRPML2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call